You are here

Article info

Article menu
Download PDFPDF
Clinical and epidemiological research
Concise report
Efficacy and safety of long-term low molecular weight heparin in patients with antiphospholipid syndrome

Authors

  1. Correspondence to Munther A Khamashta, Lupus Research Unit, The Rayne Institute, 4th Floor Lambeth Wing, St Thomas‘ Hospital, London SE1 7EH, UK; munther.khamashta{at}kcl.ac.uk
View Full Text

Citation

Vargas-Hitos JA, Ateka-Barrutia O, Sangle S, et al
Efficacy and safety of long-term low molecular weight heparin in patients with antiphospholipid syndrome
Annals of the Rheumatic Diseases 2011;70:1652-1654.

Publication history

  • Accepted May 1, 2011
  • First published May 30, 2011.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions